1. Home
  2. DWSN vs CTSO Comparison

DWSN vs CTSO Comparison

Compare DWSN & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DWSN

Dawson Geophysical Company

HOLD

Current Price

$1.96

Market Cap

58.4M

Sector

Energy

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.73

Market Cap

49.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DWSN
CTSO
Founded
1952
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.4M
49.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DWSN
CTSO
Price
$1.96
$0.73
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
34.8K
126.1K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$64,312,000.00
$36,979,520.00
Revenue This Year
N/A
$9.51
Revenue Next Year
N/A
$24.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
23.89
52 Week Low
$1.08
$0.60
52 Week High
$5.54
$1.61

Technical Indicators

Market Signals
Indicator
DWSN
CTSO
Relative Strength Index (RSI) 50.37 46.64
Support Level $1.92 $0.70
Resistance Level $2.03 $0.85
Average True Range (ATR) 0.10 0.07
MACD -0.00 0.01
Stochastic Oscillator 48.70 52.04

Price Performance

Historical Comparison
DWSN
CTSO

About DWSN Dawson Geophysical Company

Dawson Geophysical Co is a provider of onshore seismic data acquisition services with operations throughout the continental United States and Canada. The company acquires and processes 2 D, 3 D, and multi-component seismic data for clients, ranging from oil and gas companies to independent oil and gas operators for use in the onshore drilling and production of oil and natural gas as well as provides multi-client data libraries. It operates through a single segment being Contract seismic data acquisition and processing services. In addition, the company provides multi-component seismic data surveys which involve the recording of alternative seismic waves. Geographically, it generates maximum revenue from the United States.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: